Skip to content
GovLens is in free beta — full access while we build. Join the beta →

GIANNOTTI: Nuova disciplina della classificazione, della determinazione dei prezzi edelle modalità di rimborso dei medicinali

Stage otherUpdated 5mo ago

This procedure proposes new rules for classifying medicines, setting their prices, and determining how they are reimbursed. The aim is to create a more transparent and efficient system for pharmaceutical products. These changes will affect pharmaceutical companies, healthcare providers, and ultimately patients by influencing the availability and cost of medicines within the Italian healthcare system.